Digital Ulcers In Systemic Sclerosis clinical trials

Explore recruiting digital ulcers in systemic sclerosis clinical trials.

Recruiting digital ulcers in systemic sclerosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Digital Ulcers In Systemic Sclerosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Local and systemic safety and tolerability of ascending doses of TOP-N53, a nitric oxide (NO)-releasing phosphodiesterase-5 (PDE5) inhibitor, administered topically, on wound in patients with digital ulcers (DU) in systemic sclerosis (SSc) in an open-label, vehicle-controlled, phase 2a, multi-center clinical trial

France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Digital Ulcers In Systemic Sclerosis trials by city

Digital Ulcers In Systemic Sclerosis in Toronto Digital Ulcers In Systemic Sclerosis in Vancouver Digital Ulcers In Systemic Sclerosis in Montreal Digital Ulcers In Systemic Sclerosis in Calgary Digital Ulcers In Systemic Sclerosis in Edmonton Digital Ulcers In Systemic Sclerosis in Ottawa Digital Ulcers In Systemic Sclerosis in Winnipeg Digital Ulcers In Systemic Sclerosis in Quebec City Digital Ulcers In Systemic Sclerosis in Hamilton Digital Ulcers In Systemic Sclerosis in Kitchener Digital Ulcers In Systemic Sclerosis in London Digital Ulcers In Systemic Sclerosis in Halifax Digital Ulcers In Systemic Sclerosis in New York Digital Ulcers In Systemic Sclerosis in Los Angeles Digital Ulcers In Systemic Sclerosis in Chicago Digital Ulcers In Systemic Sclerosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease